NOT KNOWN DETAILS ABOUT RESTORIL CAPSULES

Concomitant use of oxycodone HCl with CYP3A4 inducers or discontinuation of an CYP3A4 inhibitor could lessen oxycodone plasma concentrations, decrease opioid efficacy or, probably, bring about a withdrawal syndrome within a patient who had produced physical dependence to oxycodone.Suggest each people and caregivers regarding the challenges of respi